Our news

tomdenhartmemorial

Tom Denhart Memorial Golf Tournament

The second event in the PAR for Life Golf Series will be held on Monday October 4, 2010 at Columbia Edgewater Country Club in Portland, OR. The 18-hole scramble will… continue reading

Another example of what we eat making a difference.

Listen to William Li talk about the work and learnings of the Angiogenesis Foundation. He recently gave a TED talk in Los Angeles and shows how what we eat not… continue reading

Life Saver Cocktail is launched

PAR for Life has developed a new cocktail to be carried by local restaurants to help raise awareness and funds for prostate cancer. The Life Saver Cocktail was launched at… continue reading

American cancer society releases annual cancer statistics

According to information just released by the American Cancer Society cancer deaths continue to decrease. Prostate cancer alone will account for one in four (28 percent, 217,730 cases) of all cancer… continue reading

New chemotheraphy drug approved by the FDA

The U.S. Food and Drug Administration (FDA) has recently approved a new drug for the treatment of the advanced stage of prostate cancer. The chemotherapy drug Jevanta was reviewed under… continue reading

Video of PAR for Life Golf Series Ball Drop on May 29, 2010.

Congratulations to Kathryn Shapton the winner of the Ball Drop during the first PAR for Life Golf Series Event. On the evening of May 29, 2010 during the Mahina Young… continue reading
  • Posted June 4, 2010
  • Video

OHSU newsletter features PAR for Life

The Spring/Summer 2010 issue of the OHSU Knight Cancer Institute Newsletter features PAR for Life and the Denhart family’s support of the institute’s prostate cancer program. “Tom was an incredible man.… continue reading

Pomegranates pack a punch

Studies on men with prostate cancer have shown that the consumption of pomegranate juice lengthened the PSA doubling time from 15 months before to 54 months on the juice. Pomegranate… continue reading

FDA approves a new theraphy for advanced prostate cancer

Last week the Food and Drug Administration approved Provenge, a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.  This… continue reading

Prostate cancer vaccine awaits FDA approval

Dr. Jennifer Ashton discusses the study of a prostate cancer vaccine that is awaiting FDA approval on CBS’s “The Early… continue reading
  • Posted April 27, 2010
  • Video

Prostate cancer risk factors

Tomasz Beer, MD Oregon Health & Science University and PAR for Life Scientific Advisory Board member discusses prostate cancer risks. More information is available at… continue reading
  • Posted April 20, 2010
  • Video
  • Page 1 of 2
  • 1
  • 2
  • >